Sign In
Pharma
US tariffs: Only Sun Pharma exposed to some headline risk
Impact on Indian pharma unlikely: IPA
Sun Pharma, Glenmark recall products in US
Sun Pharma's US arms to pay $85 million over antitrust litigation
